Morgan Stanley published a research report, with investment ratings and Target Prices for Chinese Medical related stocks listed as follows:

Stock | Investment Rating | Target Price (HKD)

HANSOH PHARMA (03692.HK) | Shareholding | 24 yuan

WUXI XDC (02268.HK) | Shareholding | 34.8 yuan

ALI HEALTH (00241.HK) | Shareholding | 5 yuan

INNOVENT BIO (01801.HK) | Shareholding | 67 yuan

AKESO (09926.HK) | Shareholding | 78 yuan

Guichuang Tongqiao - B (02190.HK) | Shareholding | 16.5 yuan

CHINARES PHARMA (03320.HK) | Shareholding | 7.5 Yuan

SINOPHARM (01099.HK) | Shareholding | 24 Yuan

(js/w)

~